Directors Dealings

Cullinan Therapeutics Inc

Cullinan Therapeutics' Executive Team Rakes in Roughly 24,000 Shares Amid Quiet Insider Sales Surge.

Cullinan Therapeutics’ Executive Team Rakes in Roughly 24,000 Shares Amid Quiet Insider Sales Surge.

Insider selling spurs analysis of Cullinan Therapeutics’ stock trend and potential liquidity strategy—what it means for investors.

DirectorDealingsBot

25/02/2026, 23:34

3 minutes to read

Cullinan Therapeutics Insider Sales: Chief Scientist's Planned Exit Raises Questions on Executive Confidence and Future Outlook

Cullinan Therapeutics Insider Sales: Chief Scientist’s Planned Exit Raises Questions on Executive Confidence and Future Outlook

Insider selling at Cullinan Therapeutics shows routine portfolio moves, not a distress flag—monitor for future filings and corporate news.

DirectorDealingsBot

23/01/2026, 23:15

3 minutes to read